Apollo Medical Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Apollo Medical Holdings generated cash of $82,128,000, which is more than the previous year. Cash used in financing activities reached the amount of -$20,085,000 last year. Net change in cash is therefore $54,930,000.
Cash Flow
| 2010 | -338.14K | 0 | 919.71K |
|---|---|---|---|
| 2011 | -245.03K | -21.16K | -2.44K |
| 2012 | -385.45K | 157.00K | -4.29K |
| 2016 | -1.83M | -247.10K | 6.34M |
| 2017 | 51.83M | 26.71M | -14.97M |
| 2018 | 25.49M | -25.18M | -11.17M |
| 2019 | 13.67M | -180.63M | 163.33M |
| 2020 | 46.16M | 95.49M | -51.69M |
| 2021 | 70.33M | 16.54M | -47.74M |
| 2022 | 82.12M | -7.11M | -20.08M |
AMEH Cash Flow Statement (2010 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 233.09M | 193.97M | 104.01M | 107.63M | 118.5M | 54.92M | 5.01M | 397.10K | 665.73K | 84.16K |
Operating activities | ||||||||||
Net income | 45.74M | 46.05M | 122.08M | 17.67M | 60.26M | 45.82M | -8.17M | -720.34K | -156.33K | -196.08K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 17.54M | 17.51M | 18.35M | 18.28M | 19.30M | 19.07M | 351.39K | 12.58K | 11.19K | 35.70K |
Stock-based compensation expense | 16.10M | 6.74M | 3.38M | 1.54M | 1.44M | 2.74M | 1.10M | 0 | 0 | 0 |
| Deferred income tax benefit | 16.10M | 6.74M | 3.38M | 1.54M | 1.44M | 2.74M | 1.10M | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -33.96M | -21.63M | 3.01M | 9.27M | -28.62M | 10.70M | -27.19K | -407.22K | -290.36K | -316.20K |
Inventories | 31.37M | 1.02M | -7.71M | -29.56M | -11.75M | 8.87M | 1.62M | 0 | 0 | 0 |
Accounts payable | -2.51M | 4.10M | 15.81M | -4.39M | -22.66M | -3.68M | 1.02M | 0 | 0 | 0 |
Cash generated by operating activities | 82.12M | 70.33M | 46.16M | 13.67M | 25.49M | 51.83M | -1.83M | -385.45K | -245.03K | -338.14K |
Investing activities | ||||||||||
Purchases Of Investments | -1.85M | -28M | -1.79M | -115.40M | -9K | -5.28K | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -22.94M | -19.22M | -1.16M | -1.04M | -1.17M | -2.08M | -262.10K | -7.20K | -21.16K | 0 |
Acquisitions Net | -18.45M | -3.90M | 31.42M | -53.00M | -17.11M | 37.34M | 0 | 164.21K | 0 | 0 |
Cash generated by investing activities | -7.11M | 16.54M | 95.49M | -180.63M | -25.18M | 26.71M | -247.10K | 157.00K | -21.16K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 12.23M | 40.13M | 10.80M | 755K | 200K | 2.16M | 200K | 0 | 0 | 0 |
Payments for dividends | -14.03M | -31.08M | -51.31M | -61.71M | -17.75M | -10.44M | 0 | 0 | 0 | 0 |
Repurchases of common stock | -9.25M | -5.73M | -537K | -7.57M | -5.04M | -3.17M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -238.53M | -9.60M | 0 | -594K | 0 | 0 | 0 | 0 | -198K |
Cash used in financing activities | -20.08M | -47.74M | -51.69M | 163.33M | -11.17M | -14.97M | 6.34M | -4.29K | -2.44K | 919.71K |
Net Change In Cash | 54.93M | 39.12M | 89.96M | -3.62M | -10.86M | 63.57M | 4.25M | -232.74K | -268.63K | 581.57K |
Cash at end of period | 288.02M | 233.09M | 193.97M | 104.01M | 107.63M | 118.50M | 9.27M | 164.36K | 397.10K | 665.73K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |